All Companies | Contract Pharma

Breaking News | Drug Development | Industry News

Kühne Holding AG Agrees to Acquire Aenova Group

Enlarges its investment portfolio to include healthcare and pharmaceutical assets.

04.24.24

Breaking News | Collaborations & Alliances | Drug Development

BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design

Collaboration will combine the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s AI/ML platform.

04.24.24

Breaking News | Collaborations & Alliances | Drug Development

Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs

Aim to revolutionize transdermal release of ‘difficult-to-formulate’ compounds targeting the endocannabinoid system.

04.24.24

Breaking News | Drug Development | Trials & Filings

Sanofi’s Rilzabrutinib Meets Primary Endpoint in ITP

Demonstrates significantly higher proportion of patients receiving rilzabrutinib achieved primary endpoint of durable platelet response versus placebo.

04.23.24

Breaking News | Collaborations & Alliances | Drug Development

Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies

Obtains rights from Washington University to develop and incorporate human HER2 directed antibodies.

04.23.24

Breaking News | Clinical Trials | Drug Development | Promotions & Moves

Calluna Names Senior Vice President of Clinical Operations & Pharmacovigilance

Margrethe Sørgaard offers 25 years’ experience in leading positions in clinical development and operation, medical affairs and drug safety/pharmacovigilance.

04.23.24

Clinical Trials | Supply Chain

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.

04.23.24

Injectables | Laboratory Testing

[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing

This webinar will cover how headspace methods are developed and validated for a variety of product-container configurations including pre-filled syringes.

Sponsored released by Lighthouse Instruments 04.22.24

Breaking News | Drug Development | Industry News

Lexeo Enters License Agreement for Friedreich Ataxia Treatment

Aims to expedite development of investigational gene therapy candidate LX2006 for the treatment of FA cardiomyopathy.

04.22.24

Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development

BioArctic, Eisai Ink Research Agreement for BAN2802 in AD

To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.

04.22.24

Clinical Trial Materials | Clinical Trials | Supply Chain

[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.

Sponsored released by Catalent Pharma Solutions 04.22.24

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research

Aim to discover and develop small molecules for the treatment of rare neurological diseases.

04.22.24

Breaking News | Collaborations & Alliances | Drug Discovery

Takeda and Astellas Agree to Establish Joint Venture Company

New joint venture aims to cover the entire drug discovery process, spanning early drug discovery research through the inception of drug discovery startups.

04.22.24

Breaking News | Drug Development | Promotions & Moves

SystImmune Names New CEO

Taps former Bristol Myers Squibb exec with 20 years’ experience in the biopharmaceutical industry.

04.22.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

RevolKa and La Jolla Institute Partner to Create Antigens for Next-Gen Vaccines

Aim to address unmet medical needs in infectious diseases.

04.19.24

Breaking News | Drug Development | Trials & Filings

Genentech's Alecensa Approved in Early-Stage NSCLC

Phase III ALINA study demonstrates Alecensa reduced the risk of disease recurrence or death by 76%.

04.19.24

Biologics, Proteins, Vaccines

Needle-Free Vaccines: Leading Innovation in Drug Delivery

Experts discuss alternative administration roots and why they matter.

Online Exclusives Charles Sternberg, Associate Editor 04.18.24

Breaking News | Collaborations & Alliances | Drug Discovery

Aurigene & Vipergen Partner to Co-Market & Offer DEL Screening Technologies to Customers

Will also co-develop new DELs with an emphasis on novel chemical diversity and drug-likeness to further strengthen their service offering.

04.18.24

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News

ExoXpert, Neucore Bio to Evaluate Advanced Exosome Loading

Aims to enable greater clarity on maximizing the therapeutic effect of Neucore’s FiXE platform as it advances clinical development.

04.18.24

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Evotec and Variant Bio Partner to Discover & Develop Treatments for Fibrosis

The partnership leverages Variant Bio’s genomic discovery capabilities and VB-Inference platform as well as Evotec’s expertise in antifibrotic drug discovery.

04.18.24